These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 32911663)
21. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1. Holmes CM; Babasyan S; Eady N; Schnabel CL; Wagner B Microbiol Spectr; 2024 Oct; 12(10):e0109224. PubMed ID: 39162558 [TBL] [Abstract][Full Text] [Related]
22. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome. Osterrieder N; Van de Walle GR Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764 [TBL] [Abstract][Full Text] [Related]
23. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066 [TBL] [Abstract][Full Text] [Related]
24. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037 [TBL] [Abstract][Full Text] [Related]
25. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Allen GP; Breathnach CC Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281 [TBL] [Abstract][Full Text] [Related]
26. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses. Zarski LM; Giessler KS; Jacob SI; Weber PSD; McCauley AG; Lee Y; Soboll Hussey G Viruses; 2021 Feb; 13(3):. PubMed ID: 33668216 [TBL] [Abstract][Full Text] [Related]
27. Cytokine responses to EHV-1 infection in immune and non-immune ponies. Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413 [TBL] [Abstract][Full Text] [Related]
28. Dual infections of equine herpesvirus 1 and equine arteritis virus in equine respiratory mucosa explants. Zhao J; Negussie H; Laval K; Poelaert KC; Nauwynck HJ Virus Res; 2016 Jul; 220():104-11. PubMed ID: 27117322 [TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry. Platt R; Sponseller BA; Chiang YW; Roth JA Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862 [TBL] [Abstract][Full Text] [Related]
30. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding. Azab W; Zajic L; Osterrieder N Vet Res; 2012 Aug; 43(1):61. PubMed ID: 22909178 [TBL] [Abstract][Full Text] [Related]
31. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice. Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744 [TBL] [Abstract][Full Text] [Related]
32. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1. Kydd JH; Davis-Poynter NJ; Birch J; Hannant D; Minke J; Audonnet JC; Antczak DF; Ellis SA J Gen Virol; 2006 Sep; 87(Pt 9):2507-2515. PubMed ID: 16894188 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses. Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350 [TBL] [Abstract][Full Text] [Related]
34. Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses. Ellis JA; Steeves E; Wright AK; Bogdan JR; Davis WC; Kanara EW; Haines DM Vet Immunol Immunopathol; 1997 Jul; 57(3-4):201-14. PubMed ID: 9261959 [TBL] [Abstract][Full Text] [Related]
35. Equine herpesvirus-1-specific interferon gamma (IFNgamma) synthesis by peripheral blood mononuclear cells in thoroughbred horses. Luce R; Shepherd M; Paillot R; Blacklawst B; Wood JL; Kydd JH Equine Vet J; 2007 May; 39(3):202-9. PubMed ID: 17520969 [TBL] [Abstract][Full Text] [Related]
36. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810 [TBL] [Abstract][Full Text] [Related]
37. Entry of equid herpesvirus 1 into CD172a+ monocytic cells. Laval K; Favoreel HW; Van Cleemput J; Poelaert KCK; Brown IK; Verhasselt B; Nauwynck HJ J Gen Virol; 2016 Mar; 97(3):733-746. PubMed ID: 26684016 [TBL] [Abstract][Full Text] [Related]
38. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852 [TBL] [Abstract][Full Text] [Related]
39. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond. Ma G; Azab W; Osterrieder N Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672 [TBL] [Abstract][Full Text] [Related]
40. Development and application of a quantitative PCR assay to study equine herpesvirus 5 invasion and replication in equine tissues in vitro and in vivo. Zarski LM; High EA; Nelli RK; Bolin SR; Williams KJ; Hussey G J Virol Methods; 2017 Oct; 248():44-53. PubMed ID: 28455133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]